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Background: Systemic hypertension may be associated with an increased pulmonary vascular resistance, which we
hypothesized could be, at least in part, mediated by increased leptin.
Methods: Vascular reactivity to phenylephrine (1 μmol/L), endothelin-1 (10 nmol/L) and leptin (0.001–100 nmol/L)
was evaluated in endothelium-intact and -denuded isolated thoracic aorta and pulmonary arteries from spontaneously
hypertensive versus control Wistar rats. Arteries were sampled for pathobiological evaluation and lung tissue for
morphometric evaluation.
Results: In control rats, endothelin-1 induced a higher level of contraction in the pulmonary artery than in the aorta.
After phenylephrine or endothelin-1 precontraction, leptin relaxed intact pulmonary artery and aortic rings, while no
response was observed in denuded arteries. Spontaneously hypertensive rats presented with increased reactivity to
phenylephrine and endothelin-1 in endothelium-intact pulmonary arteries. After endothelin-1 precontraction,
endothelium-dependent relaxation to leptin was impaired in pulmonary arteries from hypertensive rats. In both strains
of rats, aortic segments were more responsive to leptin than pulmonary artery. In hypertensive rats, pulmonary arteries
exhibited increased pulmonary artery medial thickness, associated with increased expressions of preproendothelin-1,
endothelin-1 receptors type A and B, inducible nitric oxide synthase and decreased endothelial nitric oxide synthase,
together with decreased leptin receptor and increased suppressor of cytokine signaling 3 expressions.
Conclusions: Altered pulmonary vascular reactivity in hypertension may be related to a loss of endothelial buffering
of vasoconstriction and decreased leptin-induced vasodilation in conditions of increased endothelin-1.
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It has long been known that pulmonary vascular resist-
ance (PVR) may be increased in patients with systemic
hypertension, even when left ventricular filling pressures
are within the limits of normal [1]. Guazzi et al. hypoth-
esized that this would be related to shared abnormal
smooth muscle calcium handling mechanisms in the
systemic and pulmonary resistive vessels [2]. In support
of this notion, these authors reported an enhanced* Correspondence: ldewacht@ulb.ac.be
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unless otherwise stated.pulmonary vascular reactivity to hypoxia in patients with
uncomplicated systemic hypertension [3]. However, add-
itional factors could also be implicated such as decreased
expression of nitric oxide (NO) and increased expression
of endothelin-1 [4,5] related to latent left heart failure at
rest, but increased left ventricular diastolic pressures at
exercise, as a cause of intermittent upstream transmis-
sion of mechanical stress with endothelial damage to the
pulmonary circulation. Another factor involved could be
leptin, a peptide hormone secreted by adipocytes, which
has been shown to be increased in hypertensive patients
even after adjustment for major confounders, including
obesity [6,7]. Leptin is currently thought to contribute tol Ltd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
g/publicdomain/zero/1.0/) applies to the data made available in this article,
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including sympathetic nervous system activation [8,9],
overproduction of endothelin-1 [10,11] and decreased
release of NO [12]. In patients with pulmonary arterial
hypertension, there is an increase in circulating leptin
which may contribute to inflammatory changes in the
pulmonary circulation and thereby increase PVR [13].
We, therefore, explored and compared the vascular re-
activity to endothelin-1 and leptin in isolated systemic
and pulmonary arteries from spontaneously hypertensive
(SHR) compared to control Wistar rats. The results are
compatible with the notion of abnormal pulmonary
endothelial function involving leptin and endothelin-1
control in systemic hypertension.
Methods
The present study was approved by the Institutional
Animal Care and Use Committee of the Faculty of Medi-
cine of the Université Libre de Bruxelles (Brussels,
Belgium) and was conducted in accordance with the
“Guide for the Care and Use of Laboratory Animals”
published by the US National Institutes of Health (NIH
publication no. 85 – 23, revised 1996).
Animals and sample preparation
Experiments were conducted in 18-week-old male spo-
ntaneously hypertensive (SHR) and control Wistar rats
(Janvier, Le Genest Saint-Isle, France), weighing respectively
340 ± 4 and 441 ± 10 g. During a one-week acclimatization
period, the rats were housed in a temperature (21°C)- and
relative humidity (60%)-controlled room and exposed to a
12-hour light and dark cycle. Standard rat chow and tap
water were given ad libitum.
After euthanasia of the animals with carbon dioxide,
thoracic aorta and pulmonary artery (taken after the first
branch point of the common pulmonary trunk) were
carefully excised and cleaned of blood. Adhesive fat and
connective tissue were removed. Sampled artery sections
were immediately snap-frozen and stored at −80°C for
biological evaluation, or placed in Krebs-Henseleit solu-
tion (118.1 mmol/L NaCl; 4.7 mmol/L KCl; 1.2 mmol/L
MgSO4; 1.2 mmol/L KH2PO4; 2.5 mmol/L CaCl2; 25
mmol/L NaHCO3; 5.1 mmol/L glucose) for vasoreactiv-
ity experiments.
Thoracic aortic and pulmonary artery segments were har-
vested, snap-frozen in liquid nitrogen and stored at −80°C
for biological experiments. Pulmonary tissue samples were
immediately harvested and embedded in paraffin for mor-
phometric evaluation.
Vascular reactivity
Under a dissecting microscope, thoracic aorta and pulmon-
ary artery were cut into segments of ~3 mm-length and
2.3 ± 0.1 and 1.8 ± 0.2 mm internal diameter respectively.During dissection, care was taken to protect the endothelial
lining in endothelium-intact rings. In half of the rings, the
endothelium was removed by rubbing the inner intimal
surface of the vascular lumen with a surgical steel rod to
obtain endothelium-denuded rings.
Thoracic aortic and pulmonary artery rings were moun-
ted on stainless steel hooks in 5 mL-organ baths filled with
Krebs-Henseleit solution bubbled with 95% O2 and 5%
CO2 and maintained at 37°C. One of the steel hooks was
anchored in the chamber; the other was connected to a
force transducer for continuous recording of isometric
tension by a personal computer and a chart recorder
(EMKA Technologies, Paris, France). The rings were
placed under a resting tension of 1000 mg and 600 mg for
thoracic aortic and pulmonary artery rings respectively
and were allowed to equilibrate for 60 minutes. Krebs so-
lution was changed every 20 minutes.
Thoracic aortic and pulmonary artery rings were
contracted with 80 mmol/L KCl (Sigma-Aldrich, Bornem,
Belgium) to assess their contractility. Subsequently, seg-
ments were contracted with phenylephrine hydrochloride
(1 μmol/L; Sigma-Aldrich, Bornem, Belgium) and acetyl-
choline chloride (0.001 to 10 μmol/L; Sigma-Aldrich) was
added to functionally confirm the presence of the endo-
thelium. If the tension of the vessel after administration of
acetylcholine (10 μmol/L) was under 20% or above 80%
of the phenylephrine induced precontraction, the ves-
sels were considered respectively as endothelium-intact
or -denuded. The vessels that did not belong to any
of these two groups were excluded from the present
study.
After washout period allowing return to basal vascular
tone, rat leptin (Sigma-Aldrich) was tested between
0.001 to 100 nmol/L (incubated during 2 minutes 30
seconds each) in thoracic aortic and pulmonary artery
rings preconstricted with phenylephrine (1 μmol/L). The
washout period was repeated to allow the vessel rings to
return to their basal vascular tone. Subsequently, rat lep-
tin (100 nmol/L) was tested in rings preconstricted with
endothelin-1 (10 nmol/L; Sigma-Aldrich), with ten-
sion recording every 2.5 minutes during a total of 25
minutes.
The phenylephrine (1 μmol/L) and endothelin-1 (10
nmol/L) concentrations were chosen from complete con-
centration-response curves (from 10-9 to 10-5 mol/L in log
increments; data not shown). Selected concentrations in-
duced strong artery segment constriction (> 100 mg for
the pulmonary artery and > 1000 mg for the thoracic
aorta), but were inferior to the concentrations inducing
maximal constriction.
In order to evaluate the role played by the endothelium
in the observed variations of vascular tone, experiments
were carried out in endothelium-intact and -denuded
aortic and pulmonary artery segments.
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Pulmonary arterial morphometry was performed as pre-
viously described [14,15]. Medial thickness (MT) was re-
lated to arterial size with the following formula:%MT =
(2MT/ED) × 100 and performed by counting at least 50
pulmonary arteries per lung section from each rat.
Real-time quantitative polymerase chain reaction (RTQ-PCR)
Total RNA was extracted from snap-frozen thoracic aortic
and pulmonary artery segments by homogenization ac-
cording to the method of Chomczynski and Sacchi [16],
using TRIzol reagent (Invitrogen, Merelbeke, Belgium)
and further purified using RNeasy® Mini kit (QIAGEN S.
A., Hilden, Germany) according to the manufacturer’s in-
structions. RNA concentration was determined by spec-
trophotometry (Nanodrop® ND-1000, Isogen life science,
De Meern, The Netherlands) and RNA integrity asses-
sed by visual inspection of GelRed (Biotium, Hayward,
California)-stained agarose gels.
Reverse transcription was carried out using Super-
ScriptTM II Reverse Transcriptase (Invitrogen), according
to the manufacturer’s instructions.
For RTQ-PCR, sense and anti-sense primers were de-
signed using Primer3 program for rattus norvegicus lep-
tin, leptin receptor, suppressor of cytokine signaing
3 (SOCS3), preproendothelin-1 (PPET-1), endothelin-Table 1 Primers used for real-time quantitative polymerase c
pulmonary arteries
Genes
Hypoxanthine phosphoribosyltransferase 1 (HPRT1)
Endothelin receptor type A (ETA)
Endothelin receptor type B (ETB)
Leptin
Leptin receptor
Endothelial nitric oxide synthase (eNOS)
Inducible nitric oxide synthase (iNOS)
Preproendothelin-1 (PPET-1)
Endothelin-converting enzyme 1 (ECE1)
Suppressor of cytokine signaling 3 (SOCS3)converting enzyme 1 (ECE-1), endothelin receptor type
A (ETA), endothelin receptor type B (ETB), endothelial
nitric oxide synthase (eNOS), inducible nitric oxide syn-
thase (iNOS) and hypoxanthine-guanine phosphoribosyl-
transferase (HPRT1) mRNA sequences amplification
(Table 1). To avoid inappropriate amplification of re-
sidual genomic DNA, intron-spanning primers were se-
lected when exon sequences were known and a BLAST
analysis was run to check if primer pairs were only
matching at the sequence of interest. For each sample,
amplification reaction was performed in triplicate us-
ing SYBRGreen PCR Master Mix (Quanta Biosciences,
Gaithersburg, Maryland), specific primers and diluted
template cDNA. Result analysis was performed using an
iCycler system (BioRad Laboratories, Nazareth Eke,
Belgium). Relative quantification was achieved with the
comparative 2-ΔΔCt method by normalization with the
housekeeping gene, HPRT1 [17].
Statistical analysis
All values are expressed as mean ± standard error of the
mean (SEM). Relaxations to acetylcholine or leptin were
expressed as the percentage of the maximal contractile
response developed by phenylephrine or endothelin-1.
The repeated relaxation response measurements in con-
trol Wistar and spontaneously hypertensive rats werehain reaction in rattus norvegicus thoracic aorta and
Sequences
Sense 5′ – ACAGGCCAGACTTTGTTGGA – 3′
Antisense 5′ – TCCACTTTCGCTGATGACAC – 3′
Sense 5′ – CTGGTGGCTCTTTGGATTCT – 3′
Antisense 5′ – GCTCCCATTCCTTCTGTTGA – 3′
Sense 5′ – CGATTGTATCATGCCTCGTG – 3′
Antisense 5′ – GGGACCATTTCTCATGCACT – 3′
Sense 5′ – CCTGTGGCTTTGGTCCTATC – 3′
Antisense 5′ – ATACCGACTGCGTGTGTGAA – 3′
Sense 5′ – GGACAGCCAAACAAAAGCAC – 3′
Antisense 5′ – TATCCGAGACGATTTCAGCA – 3′
Sense 5′ – GGTATTTGATGCTCGGGACT – 3′
Antisense 5′ – TGATGGCTGAACGAAGATTG – 3′
Sense 5′ – GTTTCCCCCAGTTCCTCACT – 3′
Antisense 5′ – CTCTCCATTGCCCCAGTTT –5′
Sense 5′ – CAGACCAAGGGAACAGATGC – 3′
Antisense 5′ – ACGCCTTTCTGCATGGTACT – 3′
Sense 5′ – GCCCACCAAGAACGAGATT – 3′
Antisense 5′ – GACCCCGATACCAAAGT – 3′
Sense 5′ – TGCAGGAGAGCGGATTCTAC – 3′
Antisense 5′ – AGCTGTCGCCCATAAGAAAG – 3′
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of leptin concentrations (from 0.001 to 100 nmol/L by
step of 0.1 mol/L) or the effect of time of a leptin con-
centration of 100 nmol/L (from 5 to 25 minutes by step
of 2.5 minutes) and to compare thoracic aorta and pul-
monary artery, to compare endothelium-intact and
-denuded arteries and to test the interaction between
these three factors. The repeated relaxation response
measurements in thoracic aorta and pulmonary artery
were also analyzed with a mixed linear model to assess
the effect of leptin concentrations or the effect of time
of a leptin concentration of 100 nmol/L and to compare
spontaneously hypertensive and control rat lines, to
compare endothelium-intact and -denuded arteries and
to test the interaction between these three factors. Dif-
ferences in maximal contraction to phenylephrine or
endothelin-1, RT-QPCR and morphometric data were
tested by Student t tests. A value of p < 0.05 was consid-
ered statistically significant; n represents the number of
individual data.
Results
Vascular reactivity: responses to phenylephrine and
endothelin-1
In control rats, the maximal contractile responses to
phenylephrine (1 μmol/L) were comparable in pulmonary
artery and thoracic aortic rings and were enhanced in
endothelium-denuded rings (Figure 1A). After phenyleph-
rine precontraction, acetylcholine (dose range tested from
0.001 to 10 μmol/L) induced a similar concentration-
dependent relaxation in endothelium-intact pulmonary ar-
tery and thoracic aortic rings. This relaxation was similarly
abolished in endothelium-denuded pulmonary artery and
aortic rings. The maximal relaxation responses to acetyl-
choline (10 μmol/L) in endothelium-intact pulmonary ar-
tery and aorta were, respectively, 95 ± 3% and 86 ± 2% (not
significant, p > 0.05) and in endothelium-denuded pul-
monary artery and aorta 2 ± 1% and 1 ± 1%, (not signifi-
cant, p > 0.05). In endothelium-intact and -denuded artery
rings, endothelin-1 (10 nmol/L) induced a higher level
of contraction in pulmonary artery compared to aorta
(Figure 1B). In endothelium-denuded pulmonary artery,
the contractile response to endothelin-1 (10 nmol/L) was
increased compared to the one observed in endothelium-
intact pulmonary artery (Figure 1B).
In spontaneously hypertensive rats (SHR), the maximal
contractile response to phenylephrine (1 μmol/L) was
higher in pulmonary artery compared to thoracic aortic
rings. The enhanced contractile response observed in
endothelium-denuded compared to –intact artery seg-
ments was abolished in SHR (Figure 1A). The maximal
pulmonary artery and thoracic aortic relaxation re-
sponses to acetylcholine (10 μmol/L) after phenylephrine
(1 μmol/L) precontraction were of similar magnitudein SHR compared to controls. This was observed in
endothelium-intact (92 ± 2% in SHR versus 95 ± 3% in con-
trols; not significant, p > 0.05) and endothelium-denuded
(1 ± 1% in SHR versus 2 ± 1% in controls; not significant,
p > 0.05) pulmonary artery rings.
As illustrated in Figure 1, the maximal contractile re-
sponses to phenylephrine (1 μmol/L) and to endothelin-1
(10 nmol/L) were respectively significantly and non signifi-
cantly (but with a strong tendency; p = 0.058) enhanced in
endothelium-intact pulmonary artery rings from SHR
compared to controls. These maximal contractions to
phenylephrine and to endothelin-1 were respectively 51%
and 32% higher in endothelium-denuded compared to -
intact pulmonary artery rings from controls, while these
differences were respectively reduced to 16% or even
abolished in SHR (Figure 1). These data suggest that the
endothelial negative modulation of vasoconstriction was
decreased or even abolished in SHR.
Vasoreactivity of thoracic aorta and pulmonary artery:
responses to leptin
As illustrated in Figure 2A and B, leptin (tested from
0.001 to 100 nmol/L) induced a concentration-dependent
relaxation after phenylephrine (1 μmol/L) precontraction,
rapidly reaching a plateau in endothelium-intact pulmon-
ary artery and aortic rings from control and hypertensive
rats. This vasodilating effect was more pronounced in
aorta than in pulmonary arteries in both strains of rats.
No response to leptin was observed in endothelium-
denuded arteries.
In controls, leptin (100 nmol/L) induced the relax-
ation, of endothelium-intact pulmonary artery and aortic
rings after endothelin-1 (10 nmol/L) precontraction,
while this was not observed in denuded rings (Figure 2C).
In SHR, leptin (100 nmol/L) also induced the relaxation
of endothelium-intact pulmonary artery and aortic rings
after endothelin-1 (10 nmol/L) precontraction, and this
effect was abolished in denuded aortic rings only. In-
deed, endothelium-intact and –denuded pulmonary ar-
tery rings from SHR presented with similar vasodilating
responses to leptin (100 nmol/L) after endothelin-1
(10 nmol/L) precontraction (Figure 2D). Leptin-induced
vasodilating response was more pronounced in aortic
compared to pulmonary artery rings (Figure 2C and D).
Vasoreactivity of arteries from spontaneously
hypertensive and controls rats: response to leptin
As illustrated in Figure 3A, leptin (tested from 0.001 to
100 nmol/L) induced, in thoracic aortic rings from SHR, a
stronger endothelium-dependent relaxation after phenyl-
ephrine (1 μmol/L) precontraction compared to control
aortic response. This effect was totally abolished in
endothelium-denuded rings. After endothelin-1 (10 nmol/
L) precontraction, leptin (100 nmol/L) induced a similar
Figure 1 Maximal contractile responses to phenylephrine and endothelin-1 in control Wistar and spontaneously hypertensive rats.
Comparison of contractile responses of endothelium-denuded (−) and –intact (+) thoracic aortic and pulmonary artery rings to phenylephrine
(1 μmol/L) (A) and endothelin-1 (10 nmol/L) (B). Thoracic aortic and pulmonary artery segments are collected in control Wistar rats (white bars;
n = 7-13) and in spontaneously hypertensive rats (black bars; n = 10-15). Contractile responses are expressed as the percentage of the maximal
contractile response to 80 mmol/L KCl. Results are expressed as means ± SEM. ** 0.001 < p < 0.01, *** p < 0.001 compared to the corresponding
endothelium-intact (+) artery; $ 0.01 < p < 0.05, $$$ p < 0.001 compared to the corresponding artery from the control group; ♯ 0.01 < p < 0.05,
♯♯♯ p < 0.001 compared to the thoracic artery in the same strain of rats.
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and controls. However, after endothelin-1 (10 nmol/L), lep-
tin had no effects on the vasoreactivity of endothelium-
denuded aortic rings from controls, while it induced the
contraction of denuded rings from SHR (Figure 3C).
After precontraction with phenylephrine (1 μmol/L),
leptin (tested from 0.001 to 100 nmol/L) induced, inpulmonary artery rings from SHR and control rats, a simi-
lar endothelium-dependent relaxation, which rapidly reac-
hed a plateau. This effect was totally abolished in
endothelium-denuded pulmonary artery rings (Figure 3B).
After endothelin-1 (10 nmol/L) precontraction, leptin
(100 nmol/L) induced an endothelium-dependent relax-
ation in pulmonary artery rings from control rats (p < 0.05),
Figure 2 Concentration-response curves to leptin after phenylephrine precontraction in pulmonary artery compared to thoracic aortic
segments. The endothelium-denuded (−) and –intact (+) thoracic aortic and pulmonary artery rings collected from control Wistar (A) and spontan-
eously hypertensive rats (B) were precontracted with phenylephrine (1 μmol/L) before cumulative addition of leptin (0.001 to 100 nmol/L). Relaxation
responses are expressed as the percentages of the maximal tension response obtained with 1 μmol/L phenylephrine. Response curves to leptin after
endothelin-1 precontraction in pulmonary artery compared to thoracic aortic segments. The endothelium-denuded (−) and –intact (+) thoracic aortic
and pulmonary artery rings from control Wistar rats (C) and spontaneously hypertensive rats (D) were precontracted with endothelin-1 (10 nmol/L)
before the addition of leptin (100 nmol/L). Relaxation responses are expressed as the percentages of the maximal tension response obtained with
10 nmol/L endothelin-1. Thoracic aortic and pulmonary artery segments are collected in control Wistar rats (n = 7-13) and in spontaneously hyperten-
sive rats (n = 10-15). Results are expressed as means ± SEM. *** p < 0.001 compared to the corresponding endothelium-intact (+) artery; ♯ 0.01 < p <
0.05, ♯♯ 0.001 < p < 0.01, ♯♯♯ p < 0.001 compared to the thoracic artery in the same strain of rats.
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from SHR (Figure 3D).
Pulmonary morphometry
As illustrated in Figure 4, pulmonary artery medial thick-
ness was increased in SHR compared to control rats.Pathobiological comparison of thoracic aorta and pulmonary
arteries: Endothelin-1 and nitric oxide related molecules
In control rats, gene expressions of the precursor of
endothelin-1 (the preproendothelin-1; PPET-1) and of its
converting enzyme (the endothelin converting enzyme-1;
ECE-1) were lower in pulmonary arteries compared to
Figure 3 Concentration-response curves to leptin after phenylephrine precontraction in spontaneously hypertensive compared to
control Wistar rats. The endothelium-denuded (−) and –intact (+) thoracic aortic (A) and pulmonary artery (B) rings were precontracted with
1 μmol/L phenylephrine before cumulative addition of leptin (0.001 to 100 nmol/L). Relaxation responses are expressed as the percentages of the
maximal tension response obtained with 1 μmol/L phenylephrine. Response curves to leptin after endothelin-1 precontraction in spontaneously
hypertensive rats compared to control Wistar rats. The endothelium-denuded (−) and –intact (+) thoracic aortic (C) and pulmonary artery (D)
rings were precontracted with endothelin-1 (10 nmol/L) before addition of leptin (100 nmol/L). Relaxation responses are expressed as the per-
centages of the maximal tension response obtained with 10 nmol/L endothelin-1. Thoracic aortic and pulmonary artery segments are collected in
control Wistar rats (n = 7-13) and in spontaneously hypertensive rats (n = 10-15). Results are expressed as means ± SEM. * 0.01 < p < 0.05, *** p <
0.001 compared to the corresponding endothelium-intact (+) artery; $$$ p < 0.001 compared to the corresponding artery from the control group.
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(ETA) and type B (ETB) expressions were respectively
higher and unchanged (Figure 5C-D).
In SHR, expressions of PPET-1, ETA and ETB receptors
were increased in pulmonary arteries compared to aorta,
while ECE-1 expression remained unchanged (Figure
5A-D). Gene expression of inducible nitric oxide (iNOS)was reduced in pulmonary arteries compared to aorta,
while endothelial nitric oxide (eNOS) expression remained
unchanged (Figure 5E-F).
In thoracic arteries, eNOS expression was decreased in
SHR compared to controls, while expression of iNOS
was increased (Figure 5E-F). In pulmonary arteries from
SHR, expressions of PPET-1, ETA and ETB receptors
Figure 4 Representative slides of pulmonary arterioles
obtained from control Wistar and from spontaneously
hypertensive rats. Hematoxyllin-Eosin method staining (A; scale
bars: 50 μm). Morphometry on pulmonary arterioles expressed as
the medial thickness percentage versus the pulmonary artery
external diameter in control Wistar rats (n = 6; white bars) and in
spontaneously hypertensive rats (n = 6; black bars) pigs (B). Values
are expressed as mean ± SEM. $ 0.01 < p < 0.05 compared to the
control pulmonary artery.
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ned unchanged (Figure 5A-D and F). Pulmonary artery
gene expression of eNOS was decreased in SHR com-
pared to controls (Figure 5E).Thoracic aorta and pulmonary artery expressions of leptin
and related molecules
In control rat and SHR, gene expression of leptin was lower
in pulmonary artery than in thoracic aorta (Figure 6A),
while leptin receptor gene expression was higher
(Figure 6B).
In SHR, pulmonary artery and thoracic aorta expres-
sion of leptin receptor was decreased compared to con-
trols (Figure 6B), while leptin expression did not change
(Figure 6A). Gene expression of suppressor of cytokine
signaling-3 (SOCS-3), which has been shown to inhibit
the signal transduction processes of leptin and to be im-
plicated in leptin resistance [18], was increased in pul-
monary arteries from SHR compared to controls
(Figure 6C).Discussion
The present study shows that vascular reactivity to
endothelin-1 and leptin differs between pulmonary and
systemic arteries and between pulmonary arteries from
spontaneously hypertensive and normotensive rats. In-
deed, the vasoconstriction induced by endothelin-1 is
stronger in pulmonary compared to systemic arteries,
and leptin induces more endothelium-dependent vasore-
laxation in systemic compared to pulmonary arteries. In
spontaneously hypertensive rats, the pulmonary artery
vasoconstriction induced by phenylephrine and by endo-
thelin-1 is enhanced due to a loss of the endothelial
negative modulation of vasoconstriction. Moreover, leptin-
induced pulmonary artery vasodilation after endothelin-1
precontraction is decreased in this hypertensive strain of
rats, while leptin-induced thoracic aortic vasodilatation is
preserved.
In the present study, pulmonary and systemic arteries
were different in terms of vascular reactivity to different
vasoactive agents (endothelin-1 and leptin). This is con-
sistent with previous report showing that the mecha-
nisms underlying the regulation of the vascular tone are
different in pulmonary and systemic arteries, including
calcium sensitization, channel activation/opening and
superoxide effects [19]. An important role for the
endothelin system has been well established in pulmon-
ary arterial hypertension with demonstrated beneficial
effects of endothelin receptor antagonists in these pa-
tients [20]. In contrast, the use of endothelin receptor
antagonists has been disappointing in systemic cardio-
vascular diseases [21]. This is consistent with the present
results and with previous results [22], showing enhanced
pulmonary vasoreactivity to endothelin-1 in experimen-
tal heart failure. Here, high pulmonary vasoreactivity to
endothelin-1 was associated with increased expression of
ETA receptor in pulmonary compared to systemic arter-
ies, while ETB receptor expression was similar. Indeed, it
appears that the stimulation of the ETA receptors on the
smooth muscle cells causes vasoconstriction that is op-
posed by stimulation of the ETB receptors present on
the endothelial cells.
Leptin is a multifactorial adipose-derived adipokine
that plays a critical role in bodyweight homeostasis and
energy expenditure. Plasma leptin levels are markedly
increased in obesity and associated metabolic syndrome.
However, leptin levels have also been shown to be in-
creased in patients with systemic hypertension [6,7] and
pulmonary arterial hypertension [13], independently of
their body mass index. The effects of leptin on systemic
vasculature have been previously reported [23-26], but
there is still no data regarding the pulmonary vascular
effects of leptin. Under physiological conditions, leptin
has no effect on systemic blood pressure, probably be-
cause its sympathetic nervous system stimulation is
Figure 5 Expression of genes implicated in the endothelin-1 and nitric oxide signaling pathways. Relative gene expressions of the
preproendothelin-1 (PPET-1, A), the endothelin converting enzyme-1 (ECE-1; B), the endothelin receptor type A (ETA; C), the endothelin receptor
type B (ETB; D) and the endothelial (eNOS; E) and the inducible (iNOS; F) nitric oxide synthase in thoracic aorta and pulmonary artery from control
Wistar rats and from spontaneously hypertensive rats (SHR). Results are expressed as means ± SEM. $ 0.01 < p < 0.05 compared to the corresponding
artery from the control group; ♯ 0.01 < p < 0.05, ♯♯ 0.001 < p < 0.01 compared to the thoracic artery in the same strain of rats.
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thelium–dependent vasorelaxation by endothelial nitric
oxide and endothelium-derived hyperpolarizing factor.
In contrast, in pathological chronic hyperleptinemia, the
NO-mediated vasodilatory effects are impaired contrib-
uting to the development of hypertension, together with
oxidative stress and overproduction of endothelin-1.
Here, we found an endothelium-dependent vasodilating
effect of leptin on isolated precontracted control sys-
temic and pulmonary artery rings, with higher magni-
tude in systemic ones. This suggests that the systemic
circulation is more prone to relax after leptin stimula-
tion than the pulmonary circulation and that the endo-
thelial integrity is critical for leptin vasodilation in both
types of vessels. The decreased vasodilating response to
leptin observed in the pulmonary arteries was associatedwith increased ETA receptor expressions together with
increased leptin receptor expression. Indeed, despite a
higher gene expression of leptin receptor in pulmonary
artery, aortic rings were more responsive to leptin than
pulmonary artery rings.
Beside systemic hypertension, spontaneously hyperten-
sive rats have been shown to develop pulmonary hyper-
tension spontaneously [27] or after exposure to chronic
hypoxia [28]. In the pulmonary artery from these hyper-
tensive rats, we found increased expressions of the
endothelin-1 precursor, ETA and ETB receptors and de-
creased expression of endothelial NO synthase. These al-
terations of the vasodilator/constrictor balance (in favor
of increased vasoconstriction) present some similarities
with those observed in patients with pulmonary arterial
hypertension [21,29-31]. Moreover, these pathobiological
Figure 6 Expression of genes implicated in the leptin signaling. Relative gene expressions of the leptin (A), the leptin receptor (B) and the
suppressor of cytokine signaling 3 (SOCS3; C) in thoracic aorta and pulmonary artery from control Witar rats and spontaneously hypertensive rats
(SHR). Results are expressed as means ± SEM. $ 0.01 < p < 0.05 compared to the corresponding artery from the control group; ♯ 0.01 < p < 0.05,
♯♯ 0.001 < p < 0.01, ♯♯♯ p < 0.001 compared to the thoracic artery in the same strain of rats.
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pulmonary artery remodeling. We also found increased
pulmonary artery constriction to phenylephrine and
endothelin-1 in hypertensive rats, due to the loss of the
endothelial buffering of vasoconstriction. These patho-
biological and functional alterations strongly suggest al-
tered endothelial function in the pulmonary circulation
of these hypertensive rats, probably responsible for the
development of pulmonary hypertension. This may be
considered as a type of pre-capillary component of pul-
monary hypertension that in conjunction with the pas-
sive component due to the backward transfer of the
increased pulmonary venous pressure participates to the
onset of pulmonary hypertension.
Endothelial dysfunction is an important factor in the
pathogenesis of pulmonary arterial hypertension [29]. In
our experiments, endothelial function may be easily
estimated by the difference in contraction between endo-
thelium-denuded and -intact rings. In the present study,
the endothelial blunting effect to vasoconstrictors (phenyl-
ephrine and endothelin-1) was lost in the pulmonary
arteries from hypertensive rats, suggesting pulmonary
endothelial dysfunction. This has already been shown in
systemic aortic vessels in SHR, with variable magnitude
with aging [32]. Indeed, healthy aortic endotheliumnegatively regulates α1-agonists- and endothelin-1-induced
contraction through a basal endothelial NO release [33-35],
which is partly lost in spontaneously hypertensive rats
[36-38]. The imbalance between NO and endothelin-1 sig-
naling pathways may, at least, partially mediate pulmonary
endothelial dysfunction in this hypertensive strain, together
with previously described altered calcium handling [2].
Even if we found some similar pathobiological anomalies
within the pulmonary circulation of SHR compared to
those observed in PAH patients, there is no clear evidence
that these two conditions share common early pathogenic
mechanisms.
In the present study, leptin-induced pulmonary artery
vasodilation after endothelin-1 precontraction was de-
creased in spontaneously hypertensive rats, suggesting
that, in these rats, an impairment of leptin negative
modulation against endothelin-1 vasoconstriction could
participate to the increase in pulmonary vascular tone.
In pathologic conditions of chronic hyperleptinemia, re-
sistance to the vasodilatory effects of leptin has already
been described in the systemic circulation [26,39] and
incriminated in the development of systemic arterial
hypertension owing to unopposed stimulation of the
sympathetic nervous system by this hormone. This has
been attributed to an abrogated effect of leptin on NO
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ferent mechanisms, including an imbalance between lep-
tin and leptin-binding proteins in the blood, a receptor
downregulation or polymorphism, and post-receptor de-
fects [41]. Suppressor of cytokine signaling 3 (SOCS3) is
a critical negative feedback regulator of leptin receptor
signaling that has been shown to contribute to the devel-
opment of leptin resistance through inhibition of signal
transduction [42]. In the present study, leptin receptor
expression was downregulated and SOCS3 expression
was upregulated in the pulmonary arteries of spontan-
eously hypertensive compared to normotensive rats.
These could, therefore, contribute to the leptin resist-
ance observed in the pulmonary vasculature of the
hypertensive rats.
Conclusions
The present study shows that endothelin-1-induced
vasoconstriction is more potent in the pulmonary artery
than in the aorta and that this constriction is potentiated
in spontaneous hypertensive rats, probably due to pul-
monary endothelial dysfunction. The endothelium-depen-
dent vasodilation induced by leptin is less effective in the
pulmonary artery than in the aorta and this effect is abro-
gated after endothelin-1 precontraction in spontaneously
hypertensive rats. The fact that this could be related to
leptin resistance needs further investigation.
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